Cancer

Cancer

We are now realising we deserve more and for me it's teaching women what to say so they get taken seriously. Women on the whole - I wasn't - aren't very good at standing up for ourselves.

Nancy Doherty claimed that her employer reduced her hours because it no longer wanted her as the 'face' of the business after her cancer treatment.

Dr. Bishop and Varmus showed that oncogenes - genes that cause cancer - are not foreign genes introduced into the body by viruses, as was widely believed at the time. Instead, normal versions of oncogenes are present in healthy cells, where they help regulate normal growth.

The analysis by Food & Water Watch found that 60% of counties with high glyphosate use had non-Hodgkin lymphoma rates above the national average, indicating a strong correlation between glyphosate application and cancer incidence.

Using CRISPR-Cas9 and adeno-associated virus (AAV)-mediated homology-directed repair, we targeted CAR integration into the endogenous human TCR alpha locus (TRAC). TRAC-CAR T cells display dynamic CAR expression that delays exhaustion and improves tumour control in xenograft and immunocompetent models. This work has been critical for the development of allogeneic CAR T cell therapy, as it disrupts the TCR after transgene insertion—a necessary step to limit graft-versus-host disease.

I went to ChatGPT and came up with a plan on how to do this. He also used AlphaFold, an AI tool from Google's DeepMind, to find mutated proteins that could be potential targets for treatment. While an immunotherapy treatment that looked like a good fit for Rosie was identified, the drugmaker wouldn't provide it.

I'm doing it one, to feel good about myself, but two, for The Bachelorette. Normally, if you know me, I'm not in dresses. So I just kind of want to feel good in them. The touch-up procedure took place five days before filming the Season 3 reunion, demonstrating Taylor's deliberate preparation for her new role as the show's lead.

A report last year found unnecessary surgeries were carried out, cancers were missed and poor standards of care were delivered at the University Hospital of North Durham and Darlington Memorial Hospital. CDDTF said it wanted to support the patients it had let down, including by offering access to psychological support, and to ensure they knew how to make a claim or raise concerns with police.

According to the patent, a specific crystalline form of the drug known as polymorph C may be more effective than other versions because it is absorbed more efficiently by the body. The patent also notes that laboratory studies showed the drug reduced tumor growth and helped mice with brain tumors live longer, prompting early clinical trials to test whether the treatment is safe and effective in humans.

These figures represent decades of crucial scientific breakthroughs. From vaccines that prevent cancer to kinder, more targeted treatments. Because of this, thousands more people today can make memories, reach milestones and spend precious time with their loved ones.

X4 Pharmaceuticals drew a fresh initiation from Guggenheim, which assigned a Buy rating and $12 price target, framing the company as a "differentiated hematology play" with significant upside in the next 18 months. The firm's thesis centers on mavorixafor, a potential first-in-class oral CXCR4 antagonist already approved for WHIM syndrome and currently in Phase 3 development for primary chronic neutropenia.

I'm resilient. I've been through lots of highs and lows including a health battle with cancer and I'm still here, still standing, still singing.

I have been hassling doctors at Derriford Hospital to start. I thought we would be back on Sunday and now I am worried the cancer will get worse because I have not had chemo in time.

We thought it was a growth thing... we thought maybe she didn't have enough sleep... it all seemed within the realm of normal childhood stuff. Her eyes were swollen... that was the first sign that something was different. So that's when we took her to the doctor.

This study is really good news for those who follow a vegetarian diet because they have a lower risk of five cancer types, some of which are very prevalent in the population. While being vegetarian appeared to be protective overall, the scientists also found that those who follow a vegetarian diet had nearly double the risk of the most common type of cancer of the oesophagus, known as squamous cell carcinoma, compared with meat eaters.

Overall, vegetarians had a lower risk of five kinds of cancer, including some of the most lethal cancers, like breast cancer and prostate cancer. Pescatarians also had a lower risk of colorectal, breast, and kidney cancer, compared to red meat eaters, and poultry-eaters who avoided red meat suffered fewer cases of prostate cancer.

Survivors deserve evidence-based support that helps them live well, not confusion or guesswork. One of the most striking findings of the research was the limited and inconsistent access to evidence-based nutrition care for cancer survivors, despite clear evidence of benefit. Many survivors are motivated to improve their diet following treatment, yet often do not receive timely or appropriate guidance.

The surgery was long and grueling - almost 12 hours - and my recovery was tough. I couldn't lift my baby for weeks. My husband served as a caregiver for both me and our son, while my mom and sisters rotated shifts to help. I hated feeling like a visitor in my own life, but slowly my strength began to return. It took me about a year to fully recover and start to feel like myself again.

DNA repair deficiency, intrinsic genomic instability and an immunogenic tumour microenvironment make TNBC an interesting candidate for individualized vaccination with somatic cancer mutations that can act as neoantigens2,3. We developed an individualized neoantigen RNA vaccine approach that uses next generation sequencing (NGS) for mutation calling and predicts potentially T cell immunity-inducing neoantigens. This approach is being studied in patients with melanoma and pancreatic and other solid cancers4,5,6,7 (Extended Data Fig. 1a).

Scientists in the laboratory of Rendong Yang, PhD, associate professor of Urology, have developed a new large language model that can interpret transcriptomic data in cancer cell lines more accurately than conventional approaches, as detailed in a recent study published in Nature Communications. Long-read RNA sequencing technologies have transformed transcriptomics research by detecting complex RNA splicing and gene fusion events that have often been missed by conventional short-read RNA-sequencing methods.